Departed
Joseph W. Dziedzic
Director
ITGR ·
Integer Holdings Corp
Mr. Dziedzic will retire as President and CEO and step down from the Board, effective October 24, 2025.
Ready 8-Ks
28
Latest filing
May 22, 2026, 4:17 PM ET
Top materiality
0.90
Event mix
other_material ×8 · earnings ×8 · debt ×7
Sentiment
10 pos · 0 neg · 18 neu
Latest earnings
reported 2025-FY
Executive change
recent →
Recent 8-K filings for ITGR
Highest-materiality recent filing
Integer Holdings Q2 2025 Sales Up 11% to $476M, Raises Full-Year Profit Outlook
- Sales increased 11% to $476 million in Q2 2025, driven by strong Cardio & Vascular growth of 24%.
- GAAP operating income rose 9% to $59 million; adjusted operating income up 15% to $81 million.
-
Stockholders approved the 2026 Omnibus Incentive Plan, adding 1,000,000 new shares plus carryover from prior plan.
-
Integer reports Q1 sales $440M (+0.5%), adj EPS $1.20; board starts strategic review
Q1 sales $440M (+0.5% reported, +1.3% organic); GAAP op income $32M (-36%), adj op income $61M (-14%).
-
Integer Holdings adds two directors, cuts board size, in Irenic Capital cooperation deal
James Flanagan and Aaron Kapito appointed to Board effective March 12, 2026 as part of cooperation agreement with Irenic Capital Management.
-
Integer reports Q4 adjusted EPS $1.76, 23% YoY growth; full year adjusted EPS $6.40, up 21%
Q4 sales $472M (+5% YoY); GAAP EPS $1.38, adjusted EPS $1.76 (+23%).
-
Integer Holdings authorizes $200M share repurchase program, no expiration date
Board approved up to $200M of common stock repurchases on Nov 3, 2025.
-
Payman Khales becomes Integer President and CEO, succeeding retiring Joseph Dziedzic
Khales appointed CEO and board member effective Oct. 24, 2025; Dziedzic serves as advisor through March 31, 2026.
-
Integer Q3 sales up 8% to $468M; non-GAAP EPS $1.79, up 25% YoY; updates 2025 outlook
GAAP diluted EPS from continuing ops $1.11 (+10% YoY); non-GAAP adjusted EPS $1.79 (+25%).
-
Integer Holdings Q2 2025 Sales Up 11% to $476M, Raises Full-Year Profit Outlook
Sales increased 11% to $476 million in Q2 2025, driven by strong Cardio & Vascular growth of 24%.
-
Integer appoints Michael Coyle to Board; brings 40+ years medtech leadership
Michael Coyle appointed to Integer's Board of Directors effective July 10, 2025.
-
Notes convertible July 1–Sept 30, 2025, at option of holders after stock price condition met.
-
Integer Holdings shareholders approve officer exculpation amendment; bylaws amended
Shareholders approved officer exculpation amendment to Certificate of Incorporation (27.5M for, 5.1M against); filed with Delaware on May 23.
-
Integer Q1 sales +7% to $437M, adjusted EPS $1.31; raises 2025 adjusted EPS outlook
Sales $437M (+7% YoY), organic +6%; Cardio & Vascular +17%, Cardiac Rhythm Management & Neuromodulation +2%.
-
Integer Holdings CEO Joseph Dziedzic to retire Oct 24, 2025; COO Payman Khales named successor
CEO Joseph Dziedzic will retire effective October 24, 2025; will serve as Special Advisor through March 31, 2026.
-
Integer says tariffs to have immaterial impact; $1-5M hit to FY adj. operating income
Estimates $1-5M impact on full-year adjusted operating income from tariffs.
-
Integer announces conversion period for 2.125% Convertible Notes due 2028
Notes convertible at holder's option from April 1 through June 30, 2025.
-
Integer closes $1B 1.875% convertible notes offering; expects ~$12M interest savings
Closed $1B aggregate principal of 1.875% Convertible Senior Notes due 2030, upsized from $750M to $875M plus full $125M option.
-
Integer Holdings prices $875M convertible notes at 1.875%, exchanges $383.7M of existing notes
Priced $875M of 1.875% convertible senior notes due 2030, upsized from $750M.
-
Integer launches $750M convertible note offering due 2030, with $125M option
Aggregate principal amount of $750M convertible senior notes due March 15, 2030; initial purchasers can buy up to $125M more.
-
Integer director William B. Summers to retire at 2025 annual meeting, not seeking re-election
William B. Summers, Jr. will not stand for re-election and retires from the Board at the conclusion of his term effective with the 2025 annual meeting.
-
Integer Q4 sales +11% to $449M, adj EPS $1.43; 2025 guidance calls for 8-10% sales growth
Q4 sales $449M (+11% YoY), GAAP EPS $0.91 (+15%), adjusted EPS $1.43 (+1%).
-
Integer announces conversion period for 2.125% Convertible Senior Notes due 2028
Notes convertible Jan 1–Mar 31, 2025 at 11.4681 shares per $1,000 principal (~$87.20/share).
-
Integer Q3 sales +9% to $431M; raises FY outlook; promotes Khales to COO
Q3 sales $431M (+9% YoY), organic +4%; GAAP op income $58M (+19%), adj op income $76M (+17%).
-
Integer Holdings 2.125% convertible notes become convertible in Q4 2024 after stock price trigger
Notes convertible Oct 1-Dec 31, 2024; conversion rate 11.4681 shares per $1,000 principal (~$87.20/share).
-
Integer Q2 2024 sales up 9% to $436M, GAAP EPS $0.88, adj. EPS $1.30; raises profit outlook
Sales $436M (+9% YoY, organic +5%); GAAP net income $31M (+30%); adj. net income $45M (+17%).
-
Integer Holdings General Counsel to retire Jan 31, 2025; successor search underway
McAlister C. Marshall, II, SVP, General Counsel & Corporate Secretary, plans to retire effective Jan 31, 2025.
-
Integer upsizes revolver by $300M to $800M; notes become convertible in Q3
Increased revolving credit facility from $500M to $800M via third amendment to credit agreement dated July 1, 2024.
-
11 director nominees elected, including Sheila Antrum, Pamela Bailey, Cheryl Capps, Joseph Dziedzic, among others.
-
Integer Q1 sales up 10% to $415M, adjusted EPS $1.14; reiterates FY2024 outlook
Sales of $415M (+10% YoY), organic growth 6%; GAAP net income $21M (+57%), diluted EPS $0.59.
Executive changes
Appointed
Payman Khales
Director
ITGR ·
Integer Holdings Corp
the Company expects that Mr. Khales will be elected to the Board on that same day.
Appointed
Joseph W. Dziedzic
Special Advisor
ITGR ·
Integer Holdings Corp
Mr. Dziedzic will continue to serve as President and CEO until October 24, 2025, when Mr. Dziedzic will transition to non-executive employment with the Company as a Special Advisor.
Departed
Joseph W. Dziedzic
President and Chief Executive Officer
ITGR ·
Integer Holdings Corp
Mr. Dziedzic will retire as President and CEO and step down from the Board, effective October 24, 2025.
Appointed
Payman Khales
President and Chief Executive Officer
ITGR ·
Integer Holdings Corp
the Board also appointed Payman Khales, the Company’s current Chief Operating Officer, to succeed Mr. Dziedzic as President and CEO
Departed
William B. Summers, Jr.
Director
ITGR ·
Integer Holdings Corp
On February 27, 2025, William B. Summers, Jr. notified Integer Holdings Corporation (the “Company”) that he will not stand for re-election and will retire from the Company’s Board of Directors at the conclusion of his term effective with the Company’s 2025 annual meeting of stockholders.
Role change
Andrew Senn
President, Cardio and Vascular
ITGR ·
Integer Holdings Corp
In connection therewith, Andrew Senn, who currently serves as Senior Vice President, Strategy, Business Development and Investor Relations, has been appointed to serve as President, Cardio and Vascular.
Role change
Payman Khales
Chief Operating Officer
ITGR ·
Integer Holdings Corp
On October 24, 2024, the Company announced that Payman Khales, who currently serves as the Company’s President, Cardio & Vascular, has been promoted to serve in the newly created role of Chief Operating Officer.
Departed
McAlister C. Marshall, II
Senior Vice President, General Counsel and Corporate Secretary
ITGR ·
Integer Holdings Corp
On July 8, 2024, McAlister C. Marshall, II, Senior Vice President, General Counsel and Corporate Secretary of Integer Holdings Corporation (the “Company”), notified the Company that he plans to retire from the Company effective January 31, 2025.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.90 · Median 0.65 · Most common event other_material